The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "hold"
Wall Street's median 12-month price target for Edgewell Personal Care Company is $28.50, about 0.1% above its August 4 closing price of $28.53
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 11 three months ago
Outlook narrowed for FY26 sales
Edgewell narrows FY26 reported net sales growth to 1.3%-1.8% from 0.8%-3.8%
Company expects FY26 organic net sales to be flat to up 0.5%, vs prior -1% to +2%
Edgewell maintains FY26 adjusted EPS outlook at $1.80-$2.00, mid-point unchanged
Quarterly results miss on sales and EBITDA
U.S. personal care firm's fiscal Q3 sales rose 1.7% but missed analyst expectations
Adjusted EPS for fiscal Q3 was flat yr/yr and beat analyst expectations
Adjusted EBITDA for fiscal Q3 declined and missed analyst expectations
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
North America recovery offset by international weakness and higher costs
North America recovery - Organic sales in North America rose 3%, driven by volume growth in Sun, Skin Care and Grooming, reflecting improved execution, increased distribution and strength in priority brands
International weakness - International organic sales fell 1.4%, mainly due to temporary disruption from the Middle East conflict and supply chain impacts from Wet Shave manufacturing consolidation
Higher costs and promotions - Gross margin declined as productivity savings and favorable currency were outweighed by inflation, tariffs, and unfavorable mix and promotional levels
EPC•
